RAMP1
Receptor activity-modifying protein 1
As of the edition of 20 October 2026, RAMP1 (receptor activity-modifying protein 1, UniProt O60894) has 1 drug tested at it and 1 company on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- O60894
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Solved structures
- 25
- Disease areas
- Nutrition and metabolism
- Registered trials of its drugs
- 1
Drugs at this target
| Status | Count |
|---|---|
| Went quiet | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Davalintide | Went quiet | Phase 2 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 1 |
| Total on the list | 1 |